Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.89B |
| 2 |
Tesla
TSLA
|
+$788M |
| 3 |
Broadcom
AVGO
|
+$772M |
| 4 |
Amazon
AMZN
|
+$768M |
| 5 |
Workday
WDAY
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.5B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$898M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$565M |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$441M |
| 5 |
Palo Alto Networks
PANW
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.36% |
| 2 | Consumer Discretionary | 2.24% |
| 3 | Healthcare | 1.2% |
| 4 | Financials | 1.17% |
| 5 | Communication Services | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8576
DHI Group
DHX
$173M
| $80K | ﹤0.01% |
30,883
-10,727
| -26% | -$27.6K |
|
8577
PUT
ImmunityBio
IBRX
$8.1B
| $79.8K | ﹤0.01% |
15,900
-600
| -4% | -$1.88K |
|
|
EOD
8578
Allspring Global Dividend Opportunity Fund
EOD
$286M
| $79.4K | ﹤0.01% |
+18,297
| New | +$75K |
|
|
OPTN
8579
DELISTED
OptiNose
OPTN
| $78.9K | ﹤0.01% |
+4,077
| New | +$74.4K |
|
|
GAN
8580
DELISTED
GAN Ltd
GAN
| $78.8K | ﹤0.01% |
49,886
+37,388
| +299% | +$49.8K |
|
8581
Biote Corp
BTMD
$44.9M
| $78.6K | ﹤0.01% |
15,910
+3,065
| +24% | +$15.8K |
|
8582
Nektar Therapeutics
NKTR
$2.58B
| $78.1K | ﹤0.01% |
9,210
+7,799
| +553% | +$59.1K |
|
|
ZTR
8583
Virtus Total Return Fund
ZTR
$339M
| $77.5K | ﹤0.01% |
14,061
+3,483
| +33% | +$17.7K |
|
|
ADAP
8584
DELISTED
Adaptimmune Therapeutics
ADAP
| $77.4K | ﹤0.01% |
+97,580
| New | +$55K |
|
8585
PodcastOne
PODC
$104M
| $76.6K | ﹤0.01% |
+41,387
| New | +$91.9K |
|
8586
PepGen
PEPG
$197M
| $76.3K | ﹤0.01% |
+11,228
| New | +$61.6K |
|
|
FCO
8587
DELISTED
abrdn Global Income Fund
FCO
| $76.2K | ﹤0.01% |
+11,801
| New | +$72K |
|
|
BORR
8588
PUT
Borr Drilling
BORR
$1.19B
| $76.1K | ﹤0.01% |
+10,200
| New | +$67.2K |
|
|
CMBM
8589
DELISTED
Cambium Networks
CMBM
| $76K | ﹤0.01% |
+12,671
| New | +$62.3K |
|
|
SGMO
8590
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $75K | ﹤0.01% |
+138,038
| New | +$63.6K |
|
8591
Verrica Pharmaceuticals
VRCA
$87.3M
| $74.9K | ﹤0.01% |
+1,023
| New | +$42K |
|
8592
Taysha Gene Therapies
TSHA
$1.89B
| $74.8K | ﹤0.01% |
+42,278
| New | +$84.3K |
|
8593
Citius Pharmaceuticals
CTXR
$18.7M
| $74.7K | ﹤0.01% |
+3,948
| New | +$74.9K |
|
8594
PUT
Banco Bradesco
BBD
$36.7B
| $74.5K | ﹤0.01% |
21,300
-3,100
| -13% | -$9.73K |
|
|
JMIA
8595
PUT
Jumia Technologies
JMIA
$767M
| $74.5K | ﹤0.01% |
+21,100
| New | +$63.4K |
|
8596
Rigel Pharmaceuticals
RIGL
$750M
| $73.6K | ﹤0.01% |
5,077
+2,671
| +111% | +$27.3K |
|
8597
Apyx Medical
APYX
$171M
| $73.5K | ﹤0.01% |
+28,050
| New | +$67.9K |
|
8598
PUT
Payoneer
PAYO
$2.41B
| $73.5K | ﹤0.01% |
14,100
-49,100
| -78% | -$270K |
|
8599
Finance of America Companies
FOA
$198M
| $71.7K | ﹤0.01% |
6,514
+4,485
| +221% | +$46.1K |
|
8600
CALL
Teucrium Wheat Fund
WEAT
$292M
| $71.6K | ﹤0.01% |
2,400
-6,260
| -72% | -$181K |
|
Similar funds
Jane Street's Q4 2023 Portfolio in Review
As of Q4 2023, Jane Street held 10,187 positions worth $384B, up 24% from $309B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jane Street deployed $33.7B of net new capital in Q4 2023, opening 1,659 new positions and adding to 4,053 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, up from 2.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.5B trimmed.
- Jane Street's largest Q4 2023 buy was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
- Jane Street added most to Microsoft in Q4 2023, an estimated $1.89B increase.
- Jane Street's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.5B.
- Jane Street fully exited JPMorgan USD Emerging Markets Sovereign Bond ETF in Q4 2023, selling an estimated $121M.
- Jane Street's ten largest holdings make up 38% of its $384B portfolio in Q4 2023.
- Jane Street opened 1,659 new positions and closed 1,080 in Q4 2023.
- Jane Street's portfolio value rose 24% quarter-over-quarter to $384B.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.